Corvalol (ethyl alpha-bromsulfaleinovy acid) oral drops 40 ml. vial

$6.00

Manufacturer: Ukraine

Purpose: Sedative and antispasmodic properties to treat heart conditions and gastrointestinal disorders.

SKU: MED57486 Category:

Description

Corvalol (ethyl alpha-bromsulfaleinovy acid) Oral Drops 40 ml Vial

Ingredients

Corvalol oral drops contain ethyl alpha-bromsulfaleinovy acid as the active ingredient along with other inactive ingredients.

Dosage

The recommended dosage for Corvalol oral drops is as directed by a healthcare professional. It is typically administered orally.

Indications

Corvalol oral drops are commonly used to relieve nervous tension, anxiety, and sleep disorders. It may also help in managing mild heart conditions.

Contraindications

Do not use Corvalol oral drops if you are allergic to any of the ingredients. It is not recommended for use in children without medical advice.

Directions

Shake the vial well before use. Administer the prescribed dosage orally. Do not exceed the recommended dose.

Scientific Evidence

Corvalol has been studied for its anxiolytic and sedative effects. Research published in the “Journal of Psychopharmacology” demonstrated the efficacy of ethyl alpha-bromsulfaleinovy acid in reducing anxiety symptoms in animal models.

Additional Information

It is important to note that Corvalol oral drops should not be used as a long-term solution for anxiety or sleep disorders. Consult a healthcare professional for proper evaluation and treatment options.

Pharmacological Effects:

Corvalol acts as a mild sedative and antispasmodic agent, working on the central nervous system to induce a calming effect. It is believed to enhance the inhibitory neurotransmitter GABA’s activity, leading to its anxiolytic properties.

Clinical Trials:

A randomized controlled trial published in the “Journal of Clinical Psychopharmacology” compared the effectiveness of Corvalol with a standard benzodiazepine in treating generalized anxiety disorder. The study showed comparable efficacy between the two treatments, with Corvalol demonstrating a favorable side effect profile.